R. Korth

414 total citations
19 papers, 355 citations indexed

About

R. Korth is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Korth has authored 19 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Korth's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Platelet Disorders and Treatments (2 papers). R. Korth is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Platelet Disorders and Treatments (2 papers). R. Korth collaborates with scholars based in France, Germany and Australia. R. Korth's co-authors include Jacques Benveniste, Jocelyne Bidault, Xavier Norel, Michel Chignard, P. Braquet, B. Spinnewyn, Jean‐Pierre Le Couedic, Patrick Duriez, Jean‐Charles Fruchart and Ewa Ninio and has published in prestigious journals such as FEBS Letters, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

R. Korth

17 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Korth France 10 103 65 65 64 50 19 355
Jing‐Ren Jeng Taiwan 12 96 0.9× 47 0.7× 85 1.3× 48 0.8× 43 0.9× 20 368
C Boullet France 5 127 1.2× 30 0.5× 68 1.0× 29 0.5× 134 2.7× 8 409
Tadashi Seno Japan 6 136 1.3× 43 0.7× 68 1.0× 26 0.4× 95 1.9× 6 430
M. Braquet France 11 141 1.4× 40 0.6× 62 1.0× 24 0.4× 133 2.7× 20 546
Por J. Huang Taiwan 6 151 1.5× 57 0.9× 106 1.6× 34 0.5× 78 1.6× 8 412
Amada E Beltrán Spain 11 85 0.8× 28 0.4× 63 1.0× 52 0.8× 101 2.0× 12 369
Yawei Zheng China 12 156 1.5× 72 1.1× 51 0.8× 29 0.5× 19 0.4× 54 413
Kellie McCormick Hallam United States 6 146 1.4× 31 0.5× 67 1.0× 100 1.6× 62 1.2× 8 470
Ji Eun Lee South Korea 11 128 1.2× 44 0.7× 42 0.6× 95 1.5× 83 1.7× 17 499
Jiang Shi-sen China 11 140 1.4× 77 1.2× 83 1.3× 55 0.9× 42 0.8× 29 359

Countries citing papers authored by R. Korth

Since Specialization
Citations

This map shows the geographic impact of R. Korth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Korth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Korth more than expected).

Fields of papers citing papers by R. Korth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Korth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Korth. The network helps show where R. Korth may publish in the future.

Co-authorship network of co-authors of R. Korth

This figure shows the co-authorship network connecting the top 25 collaborators of R. Korth. A scholar is included among the top collaborators of R. Korth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Korth. R. Korth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Korth, R.. (2010). MS65 WOMEN'S HEALTH: ESTROGEN, PROGESTINS AND BLOOD PRESSURE. Atherosclerosis Supplements. 11(2). 123–123. 1 indexed citations
2.
Korth, R., M. Wenger, Paula Grest, Tony M. Glaus, & Claudia E Reusch. (2008). Hypoadrenokortizismus infolge einer bilateralen abszedierenden Nebennierenrindenentzündung bei einem Rottweiler. Zurich Open Repository and Archive (University of Zurich). 2 indexed citations
3.
Korth, R.. (2008). Aging women with LDL-related borderline syndromes. Chemistry and Physics of Lipids. 154. S47–S48.
4.
Korth, R.. (2007). PO3-59 SMOKING, BORDERLINE LDL LEVELS AND RENAL SMALL VESSEL DISEASE OF WOMEN WITH OVERWEIGHT. Atherosclerosis Supplements. 8(1). 32–33. 1 indexed citations
5.
Korth, R., Klaus F. Zimmermann, & Werner Richter. (1994). Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells. Chemistry and Physics of Lipids. 70(2). 109–119. 8 indexed citations
6.
Korth, R., et al.. (1993). Human platelets release a paf‐acether: Acetylhydrolase similar to that in plasma. Lipids. 28(3). 193–199. 35 indexed citations
7.
Korth, R. & Martin Middeke. (1991). Long time incubation of monocytic U 937 cells with LDL increases specific paf-acether binding and the cellular acetylhydrolase activity. Chemistry and Physics of Lipids. 59(3). 207–213. 12 indexed citations
8.
O’Neill, Chris, et al.. (1991). The effect of inhibitors of platelet aggregation on the metabolism of platelet‐activating factor (PAF) in washed rabbit platelets. Lipids. 26(12Part1). 1011–1014. 2 indexed citations
9.
Aepfelbacher, Martin, R. Korth, & Christian Weber. (1990). 1,25-(OH)2 vitamin D-3 enhances Paf-stimulated calcium mobilization in U937 cells by expression of specific Paf binding sites. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1051(2). 179–184. 11 indexed citations
10.
Korth, R., et al.. (1989). Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. British Journal of Pharmacology. 98(2). 653–661. 20 indexed citations
11.
Benveniste, Jacques, et al.. (1988). Preformed PAF‐acether and lyso PAF‐acether are bound to blood lipoproteins. FEBS Letters. 226(2). 371–376. 50 indexed citations
12.
Korth, R., et al.. (1988). Comparison of three paf-acether receptor antagonist ginkgolides. European Journal of Pharmacology. 152(1-2). 101–110. 28 indexed citations
13.
Korth, R., Andreas S. Reichert, U. Bicker, et al.. (1988). Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.. PubMed. 7(6). 1181–7. 24 indexed citations
14.
Korth, R. & Jacques Benveniste. (1987). BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. European Journal of Pharmacology. 142(3). 331–341. 26 indexed citations
15.
Korth, R., Hanno Riess, G. Brehm, & Erhard Hiller. (1986). Unsaturated platelet-activating factor: Influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. Thrombosis Research. 41(5). 699–706. 12 indexed citations
16.
Chignard, Michel, R. Korth, Jean‐Pierre Le Couedic, et al.. (1986). Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. European Journal of Pharmacology. 123(2). 197–205. 107 indexed citations
17.
Chignard, Michel, et al.. (1985). Comparison of BN 52021, a new inhibitor of PAF-acether-induced platelet aggregation, with kadsurenone and CV 3988. Prostaglandins. 30(4). 701–701. 3 indexed citations
19.
Korth, R., et al.. (1983). 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: Influence on aggregation and [3H] serotonin release of human thrombocytes. Chemistry and Physics of Lipids. 33(1). 47–53. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026